Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Ghim JL"" wg kryterium: Autor


Tytuł :
Pharmacokinetics of fixed-dose combination of atorvastatin and metformin compared with individual tablets
Autorzy :
Ghim JL
Phuong NTT
Kim MJ
Kim EJ
Song GS
Ahn S
Shin JG
Kim EY
Pokaż więcej
Temat :
pharmacokinetics
drug interaction
atorvastatin
metformin
food effect
Therapeutics. Pharmacology
RM1-950
Źródło :
Drug Design, Development and Therapy, Vol Volume 13, Pp 1623-1632 (2019)
Opis pliku :
electronic resource
Relacje :
https://www.dovepress.com/pharmacokinetics-of-fixed-dose-combination-of-atorvastatin-and-metform-peer-reviewed-article-DDDT; https://doaj.org/toc/1177-8881
Dostęp URL :
https://doaj.org/article/1911891de6854426b5723874c8d07d71
Czasopismo naukowe
Tytuł :
Pharmacokinetic comparison of a fixed-dose combination versus concomitant administration of amlodipine, olmesartan, and rosuvastatin in healthy adult subjects
Autorzy :
Oh M
Shin JG
Ahn S
Kim BH
Kim JY
Shin HJ
Ghim JL
Pokaż więcej
Temat :
fixed-dose combination
pharmacokinetics
amlodipine
olmesartan
rosuvastatin
Therapeutics. Pharmacology
RM1-950
Źródło :
Drug Design, Development and Therapy, Vol Volume 13, Pp 991-997 (2019)
Opis pliku :
electronic resource
Relacje :
https://www.dovepress.com/1pharmacokinetic-comparison-of-a-fixed-dose-combination-versus-co-peer-reviewed-article-DDDT; https://doaj.org/toc/1177-8881
Dostęp URL :
https://doaj.org/article/edaffaef1d27403fa0e408168785f846
Czasopismo naukowe
Tytuł :
Pharmacokinetic comparison of a fixed-dose combination versus concomitant administration of fimasartan, amlodipine, and rosuvastatin using partial replicated design in healthy adult subjects
Autorzy :
Oh M
Ghim JL
Park SE
Kim EY
Shin JG
Pokaż więcej
Temat :
replicated crossover
bioequivalence
fixed-dose combination
pharmacokinetics
fimasartan
Therapeutics. Pharmacology
RM1-950
Źródło :
Drug Design, Development and Therapy, Vol Volume 12, Pp 1157-1164 (2018)
Opis pliku :
electronic resource
Relacje :
https://www.dovepress.com/pharmacokinetic-comparison-of-a-fixed-dose-combination-versus-concomit-peer-reviewed-article-DDDT; https://doaj.org/toc/1177-8881
Dostęp URL :
https://doaj.org/article/3d18f522bed742eb99d8c9577d139ba0
Czasopismo naukowe
Tytuł :
Comparative pharmacokinetics of a fixed-dose combination vs concomitant administration of telmisartan and S-amlodipine in healthy adult volunteers
Autorzy :
Oh M
Park SE
Ghim JL
Choi YK
Shim EJ
Shin JG
Kim EY
Pokaż więcej
Temat :
Bioequivalence
fixed-dose combination
pharmacokinetics
S-amlodipine
telmisartan
Therapeutics. Pharmacology
RM1-950
Źródło :
Drug Design, Development and Therapy, Vol Volume 11, Pp 3543-3550 (2017)
Opis pliku :
electronic resource
Relacje :
https://www.dovepress.com/comparative-pharmacokinetics-of-a-fixed-dose-combination-vs-concomitan-peer-reviewed-article-DDDT; https://doaj.org/toc/1177-8881
Dostęp URL :
https://doaj.org/article/9fc1a3a66c034c52ab88550a6287e705
Czasopismo naukowe
Tytuł :
Pharmacokinetics and relative bioavailability of fixed-dose combination of clopidogrel and aspirin versus coadministration of individual formulations in healthy Korean men
Autorzy :
Choi HK
Ghim JL
Shon J
Choi YK
Jung JA
Pokaż więcej
Temat :
Fixed-dose combination
clopidogrel
aspirin
bioequivalence
Therapeutics. Pharmacology
RM1-950
Źródło :
Drug Design, Development and Therapy, Vol Volume 10, Pp 3493-3499 (2016)
Opis pliku :
electronic resource
Relacje :
https://www.dovepress.com/pharmacokinetics-and-relative-bioavailability-of-fixed-dose-combinatio-peer-reviewed-article-DDDT; https://doaj.org/toc/1177-8881
Dostęp URL :
https://doaj.org/article/8f6a800f1d8e436aba519cea5ed27c03
Czasopismo naukowe
Tytuł :
Pharmacokinetic comparison of sustained- and immediate-release formulations of cilostazol after multiple oral doses in fed healthy male Korean volunteers
Autorzy :
Kim YH
Ghim JL
Jung JA
Cho SH
Choe S
Choi HY
Bae KS
Lim HS
Pokaż więcej
Temat :
Therapeutics. Pharmacology
RM1-950
Źródło :
Drug Design, Development and Therapy, Vol 2015, Iss default, Pp 3571-3577 (2015)
Opis pliku :
electronic resource
Relacje :
http://www.dovepress.com/pharmacokinetic-comparison-of-sustained--andnbspimmediate-release-form-peer-reviewed-article-DDDT; https://doaj.org/toc/1177-8881
Dostęp URL :
https://doaj.org/article/bab0be7e06454eacbe691ae7937c9f6b
Czasopismo naukowe
Tytuł :
Pharmacokinetic equivalence of CT-P17 to high-concentration (100 mg/ml) reference adalimumab: A randomized phase I study in healthy subjects.
Autorzy :
Yu KS; Seoul National University College of Medicine and Hospital, Seoul, Korea.
Jang IJ; Seoul National University College of Medicine and Hospital, Seoul, Korea.
Lim HS; Asan Medical Center, College of Medicine, University of Ulsan, Seoul, Korea.
Hong JH; Chungnam National University Hospital, Daejeon, Korea.
Kim MG; College of Medicine, Jeonbuk National University, Jeonbuk, Korea.
Park MK; Chungbuk National University Hospital, Cheongju, Korea.
Cho DY; CHA Bundang Medical Center, CHA University, Seongnam, Korea.
Park MS; Severance Hospital, Yonsei University College of Medicine, Seoul, Korea.
Chung JY; Seoul National University Bundang Hospital, Seongnam, Korea.
Ghim JL; Inje University Busan Paik Hospital, Busan, Korea.
Lee S; Seoul National University College of Medicine and Hospital, Seoul, Korea.
Yoon SK; Asan Medical Center, College of Medicine, University of Ulsan, Seoul, Korea.
Kwon IS; Chungnam National University Hospital, Daejeon, Korea.
Lee SJ; Celltrion, Inc., Incheon, Korea.
Kim SH; Celltrion, Inc., Incheon, Korea.
Bae YJ; Celltrion, Inc., Incheon, Korea.
Cha JB; Celltrion, Inc., Incheon, Korea.
Furst DE; University of California, Los Angeles, California, USA.; University of Washington, Seattle, Washington, USA.; University of Florence, Florence, Italy.
Keystone E; Mount Sinai Hospital, University of Toronto, Toronto, Canada.
Kay J; University of Massachusetts Medical School and UMass Memorial Medical Center, Worcester, Massachusetts, USA.
Pokaż więcej
Źródło :
Clinical and translational science [Clin Transl Sci] 2021 Jan 27. Date of Electronic Publication: 2021 Jan 27.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
First-in-human, double-blind, randomized controlled trial of an oral dose of GnRH antagonist, TU2670 in healthy women.
Autorzy :
Han S; Department of Clinical Pharmacology and Therapeutics, Asan Medical Center, University of Ulsan, Seoul, Republic of Korea.
Cho YS; Department of Clinical Pharmacology and Therapeutics, Asan Medical Center, University of Ulsan, Seoul, Republic of Korea.
Yoon SK; Department of Clinical Pharmacology and Therapeutics, Asan Medical Center, University of Ulsan, Seoul, Republic of Korea.
Lim KS; Department of Clinical Pharmacology and Therapeutics, CHA University School of Medicine and CHA Bundang Medical Center, Seongnam, Republic of Korea.
Cho SH; Department of Clinical Pharmacology, Inha University Hospital, Inha University School of Medicine, Incheon, Republic of Korea.
Kim J; Clinical Trials Center, Chungnam National University Hospital, Daejeon, Republic of Korea.
Choe S; Department of Clinical Pharmacology and Therapeutics, Pusan National University Hospital, Busan, Republic of Korea.
Jung J; Department of Clinical Pharmacology and Therapeutics, Inje University Busan Paik Hospital, Busan, Republic of Korea.
Ghim JL; Department of Clinical Pharmacology and Toxicology, Anam Hospital, Korea University College of Medicine, Seoul, Republic of Korea.
Choi S; SK Chemicals, Seongnam, Republic of Korea.
Lee M; TiumBio, Seongnam, Republic of Korea.
Kim SM; TiumBio, Seongnam, Republic of Korea.
Kim HT; TiumBio, Seongnam, Republic of Korea.
Lim HS; Department of Clinical Pharmacology and Therapeutics, Asan Medical Center, University of Ulsan, Seoul, Republic of Korea.
Shim JY; Department of Obstetrics and Gynecology, Asan Medical Center, University of Ulsan, Seoul, Republic of Korea.
Bae KS; Department of Clinical Pharmacology and Therapeutics, Asan Medical Center, University of Ulsan, Seoul, Republic of Korea.
Pokaż więcej
Źródło :
The Journal of clinical endocrinology and metabolism [J Clin Endocrinol Metab] 2020 Dec 21. Date of Electronic Publication: 2020 Dec 21.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Pharmacokinetics and Pharmacodynamics of Tegoprazan Coadministered With Amoxicillin and Clarithromycin in Healthy Subjects.
Autorzy :
Ghim JL; Department of Pharmacology and Clinical Pharmacology, Pharmacogenomics Research Center, Inje University College of Medicine, Busan, Republic of Korea.; Department of Clinical Pharmacology, Inje University Busan Paik Hospital, Busan, Korea.
Chin MC; Department of Pharmacology and Clinical Pharmacology, Pharmacogenomics Research Center, Inje University College of Medicine, Busan, Republic of Korea.
Jung J; Department of Pharmacology and Clinical Pharmacology, Pharmacogenomics Research Center, Inje University College of Medicine, Busan, Republic of Korea.; Department of Clinical Pharmacology, Inje University Busan Paik Hospital, Busan, Korea.
Lee J; Division of Clinical Development, HK inno.N Corp, Seoul, Korea.
Kim S; Division of Clinical Development, HK inno.N Corp, Seoul, Korea.
Kim B; Division of Clinical Development, HK inno.N Corp, Seoul, Korea.
Song GS; Division of Clinical Development, HK inno.N Corp, Seoul, Korea.
Choi YK; Department of Pharmacology and Clinical Pharmacology, Pharmacogenomics Research Center, Inje University College of Medicine, Busan, Republic of Korea.
Shin JG; Department of Pharmacology and Clinical Pharmacology, Pharmacogenomics Research Center, Inje University College of Medicine, Busan, Republic of Korea.; Department of Clinical Pharmacology, Inje University Busan Paik Hospital, Busan, Korea.
Pokaż więcej
Źródło :
Journal of clinical pharmacology [J Clin Pharmacol] 2020 Dec 20. Date of Electronic Publication: 2020 Dec 20.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Pharmacokinetic modeling analysis of cilostazol and its active metabolites (OPC-13015 and OPC-13213) after multiple oral doses of cilostazol in healthy Korean volunteers.
Autorzy :
Cui A; Department of Clinical Pharmacology and Therapeutics, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
Kim YH; Department of Clinical Pharmacology and Therapeutics, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
Ghim JL; Department of Clinical Pharmacology, Inje University, Busan Paik Hospital, Busan, Republic of Korea.
Ah Jung J; Department of Clinical Pharmacology and Therapeutics, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
Cho SH; Department of Clinical Pharmacology, Inha University Hospital, Inha University School of Medicine, Incheon, Republic of Korea.
Choe S; Department of Clinical Pharmacology and Therapeutics, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
Choi HY; Department of Clinical Pharmacology and Therapeutics, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
Bae KS; Department of Clinical Pharmacology and Therapeutics, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
Lim HS; Department of Clinical Pharmacology and Therapeutics, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
Pokaż więcej
Źródło :
Xenobiotica; the fate of foreign compounds in biological systems [Xenobiotica] 2020 Mar; Vol. 50 (3), pp. 288-296. Date of Electronic Publication: 2019 Jul 03.
Typ publikacji :
Journal Article
MeSH Terms :
Cilostazol/*metabolism
Phosphodiesterase 3 Inhibitors/*metabolism
Adult ; Biological Availability ; Cilostazol/administration & dosage ; Female ; Humans ; Male ; Pharmacokinetics ; Phosphodiesterase 3 Inhibitors/administration & dosage ; Republic of Korea
Czasopismo naukowe
Tytuł :
Physiologically Based Pharmacokinetic Modeling Approach to Predict Drug-Drug Interactions With Ethionamide Involving Impact of Genetic Polymorphism on FMO3.
Autorzy :
Nguyen PTT; Department of Pharmacology and Clinical Pharmacology, PharmacoGenomics Research Center, Inje University College of Medicine, Busan, Republic of Korea.; Center for Personalized Precision Medicine of Tuberculosis, Inje University College of Medicine, Busan, Republic of Korea.; Faculty of Pharmacy, Hai Phong University of Medicine and Pharmacy, Hai Phong, Vietnam.
Parvez MM; Department of Pharmacology and Clinical Pharmacology, PharmacoGenomics Research Center, Inje University College of Medicine, Busan, Republic of Korea.; Center for Personalized Precision Medicine of Tuberculosis, Inje University College of Medicine, Busan, Republic of Korea.
Kim MJ; Department of Pharmacology and Clinical Pharmacology, PharmacoGenomics Research Center, Inje University College of Medicine, Busan, Republic of Korea.; Center for Personalized Precision Medicine of Tuberculosis, Inje University College of Medicine, Busan, Republic of Korea.
Yoo SE; Department of Pharmacology and Clinical Pharmacology, PharmacoGenomics Research Center, Inje University College of Medicine, Busan, Republic of Korea.; Center for Personalized Precision Medicine of Tuberculosis, Inje University College of Medicine, Busan, Republic of Korea.
Ahn S; Department of Pharmacology and Clinical Pharmacology, PharmacoGenomics Research Center, Inje University College of Medicine, Busan, Republic of Korea.; Center for Personalized Precision Medicine of Tuberculosis, Inje University College of Medicine, Busan, Republic of Korea.
Ghim JL; Department of Pharmacology and Clinical Pharmacology, PharmacoGenomics Research Center, Inje University College of Medicine, Busan, Republic of Korea.; Center for Personalized Precision Medicine of Tuberculosis, Inje University College of Medicine, Busan, Republic of Korea.; Department of Clinical Pharmacology, Inje University Busan Paik Hospital, Busan, Republic of Korea.
Shin JG; Department of Pharmacology and Clinical Pharmacology, PharmacoGenomics Research Center, Inje University College of Medicine, Busan, Republic of Korea.; Center for Personalized Precision Medicine of Tuberculosis, Inje University College of Medicine, Busan, Republic of Korea.; Department of Clinical Pharmacology, Inje University Busan Paik Hospital, Busan, Republic of Korea.
Pokaż więcej
Źródło :
Journal of clinical pharmacology [J Clin Pharmacol] 2019 Jun; Vol. 59 (6), pp. 880-889. Date of Electronic Publication: 2019 Jan 28.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Antitubercular Agents/*pharmacokinetics
Ethionamide/*pharmacokinetics
Oxygenases/*genetics
Adult ; Biological Variation, Population ; Drug Interactions ; Female ; Humans ; Liver/metabolism ; Male ; Methimazole/pharmacokinetics ; Models, Biological ; Mutation ; Polymorphism, Genetic ; Tuberculosis/drug therapy ; Tuberculosis/metabolism
Czasopismo naukowe
Tytuł :
Antiepileptic drug-induced severe cutaneous adverse reactions and HLA alleles: A report of five cases with lymphocyte activation test.
Autorzy :
Kim EY; Department of Clinical Pharmacology, Inje University College of Medicine, Busan Paik Hospital, Busan 47392, Republic of Korea.; Center for Personalized Precision Medicine of Tuberculosis, Inje University College of Medicine, Busan 47392, Republic of Korea.
Kim MY; Department of Internal Medicine, Inje University College of Medicine, Busan Paik Hospital, Busan 47392, Republic of Korea.
Park CS; Department of Internal Medicine, Inje University College of Medicine, Haeundae Paik Hospital, Busan 48108, Republic of Korea.
Choi JH; Department of Microbiology and Immunology, Inje University College of Medicine, Busan 47392, Republic of Korea.
Ghim JL; Department of Clinical Pharmacology, Inje University College of Medicine, Busan Paik Hospital, Busan 47392, Republic of Korea.; Center for Personalized Precision Medicine of Tuberculosis, Inje University College of Medicine, Busan 47392, Republic of Korea.
Kim HS; Center for Personalized Precision Medicine of Tuberculosis, Inje University College of Medicine, Busan 47392, Republic of Korea.; Department of Pharmacology and PharmacoGenomics Research Center, Inje University College of Medicine, Busan 47392, Republic of Korea.
Shin JG; Department of Clinical Pharmacology, Inje University College of Medicine, Busan Paik Hospital, Busan 47392, Republic of Korea.; Center for Personalized Precision Medicine of Tuberculosis, Inje University College of Medicine, Busan 47392, Republic of Korea.; Department of Pharmacology and PharmacoGenomics Research Center, Inje University College of Medicine, Busan 47392, Republic of Korea.
Pokaż więcej
Źródło :
Translational and clinical pharmacology [Transl Clin Pharmacol] 2019 Jun; Vol. 27 (2), pp. 64-68. Date of Electronic Publication: 2019 Jun 28.
Typ publikacji :
Case Reports
Raport
Tytuł :
A Randomized, Double-Blind Trial Comparing the Pharmacokinetics of CT-P16, a Candidate Bevacizumab Biosimilar, with its Reference Product in Healthy Adult Males.
Autorzy :
Cho SH; Inha University Hospital, Inha University School of Medicine, Incheon, Republic of Korea.
Han S; The Catholic University of Korea Seoul St. Mary's Hospital, Seoul, Republic of Korea.
Ghim JL; Inje University and Inje University Busan Paik Hospital, Busan, Republic of Korea.
Nam MS; Inha University Hospital, Inha University School of Medicine, Incheon, Republic of Korea.
Yu S; CELLTRION, Inc., Incheon, Republic of Korea.
Park T; CELLTRION, Inc., Incheon, Republic of Korea.
Kim S; CELLTRION, Inc., Incheon, Republic of Korea.
Bae J; CELLTRION, Inc., Incheon, Republic of Korea.
Shin JG; Inje University and Inje University Busan Paik Hospital, Busan, Republic of Korea. .
Pokaż więcej
Źródło :
BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy [BioDrugs] 2019 Apr; Vol. 33 (2), pp. 173-181.
Typ publikacji :
Clinical Trial, Phase I; Journal Article; Randomized Controlled Trial
MeSH Terms :
Bevacizumab/*pharmacokinetics
Biosimilar Pharmaceuticals/*pharmacokinetics
Adult ; Antibodies, Monoclonal/adverse effects ; Antibodies, Monoclonal/blood ; Antibodies, Monoclonal/pharmacokinetics ; Bevacizumab/adverse effects ; Bevacizumab/blood ; Biosimilar Pharmaceuticals/adverse effects ; Biosimilar Pharmaceuticals/blood ; Double-Blind Method ; Healthy Volunteers ; Humans ; Male ; Middle Aged ; Therapeutic Equivalency ; Young Adult
Czasopismo naukowe
Tytuł :
Effect of Cilostazol on the Pharmacokinetics of Simvastatin in Healthy Subjects.
Autorzy :
Kim JR; Department of Clinical Pharmacology and Therapeutics, Samsung Medical Center, Seoul, Republic of Korea.; Department of Clinical Research Design & Evaluation, SAIHST, Sungkyunkwan University, Seoul, Republic of Korea.
Jung JA; Department of Clinical Pharmacology and Therapeutics, Samsung Medical Center, Seoul, Republic of Korea.
Kim S; Department of Clinical Pharmacology and Therapeutics, Samsung Medical Center, Seoul, Republic of Korea.
Huh W; Department of Clinical Pharmacology and Therapeutics, Samsung Medical Center, Seoul, Republic of Korea.; Department of Internal Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
Ghim JL; Department of Clinical Pharmacology, Inje University Busan Paik Hospital, Busan, Republic of Korea.
Shin JG; Department of Clinical Pharmacology, Inje University Busan Paik Hospital, Busan, Republic of Korea.
Ko JW; Department of Clinical Pharmacology and Therapeutics, Samsung Medical Center, Seoul, Republic of Korea.
Pokaż więcej
Źródło :
BioMed research international [Biomed Res Int] 2019 Jan 09; Vol. 2019, pp. 1365180. Date of Electronic Publication: 2019 Jan 09 (Print Publication: 2019).
Typ publikacji :
Journal Article
MeSH Terms :
Drug Interactions*
Cilostazol/*administration & dosage
Cytochrome P-450 CYP3A/*genetics
Simvastatin/*pharmacokinetics
Adult ; Chromatography, Liquid ; Female ; Healthy Volunteers ; Humans ; Male ; Simvastatin/administration & dosage ; Simvastatin/analogs & derivatives ; Simvastatin/blood
Czasopismo naukowe
Tytuł :
Development of a Physiologically Based Pharmacokinetic Model of Ethionamide in the Pediatric Population by Integrating Flavin-Containing Monooxygenase 3 Maturational Changes Over Time.
Autorzy :
Nguyen PTT; Department of Pharmacology and PharmacoGenomics Research Center, Inje University College of Medicine, Busan, Republic of Korea.; Faculty of Pharmacy, Hai Phong University of Medicine and Pharmacy, Haiphong, Vietnam.
Parvez MM; Department of Pharmacology and PharmacoGenomics Research Center, Inje University College of Medicine, Busan, Republic of Korea.; Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, Canada.
Kim MJ; Department of Pharmacology and PharmacoGenomics Research Center, Inje University College of Medicine, Busan, Republic of Korea.
Ho Lee J; Department of Pharmacology and PharmacoGenomics Research Center, Inje University College of Medicine, Busan, Republic of Korea.
Ahn S; Department of Pharmacology and PharmacoGenomics Research Center, Inje University College of Medicine, Busan, Republic of Korea.
Ghim JL; Department of Pharmacology and PharmacoGenomics Research Center, Inje University College of Medicine, Busan, Republic of Korea.; Department of Clinical Pharmacology, Inje University Busan Paik Hospital, Busan, Republic of Korea.
Shin JG; Department of Pharmacology and PharmacoGenomics Research Center, Inje University College of Medicine, Busan, Republic of Korea.; Department of Clinical Pharmacology, Inje University Busan Paik Hospital, Busan, Republic of Korea.
Pokaż więcej
Źródło :
Journal of clinical pharmacology [J Clin Pharmacol] 2018 Oct; Vol. 58 (10), pp. 1347-1360. Date of Electronic Publication: 2018 Jun 07.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Antitubercular Agents/*pharmacokinetics
Ethionamide/*pharmacokinetics
Oxygenases/*metabolism
Adolescent ; Adult ; Animals ; Antitubercular Agents/administration & dosage ; Antitubercular Agents/blood ; Antitubercular Agents/pharmacology ; Area Under Curve ; Cell Line ; Child ; Child, Preschool ; Dogs ; Dose-Response Relationship, Drug ; Ethionamide/administration & dosage ; Ethionamide/blood ; Ethionamide/pharmacology ; Female ; Gene Expression Regulation, Developmental ; Gene Expression Regulation, Enzymologic ; Humans ; Infant ; Liver/metabolism ; Lung/metabolism ; Male ; Microsomes/metabolism ; Middle Aged ; Models, Biological ; Swine ; Young Adult
Czasopismo naukowe
Tytuł :
Effects of Renal Impairment on the Pharmacokinetics and Safety of Udenafil.
Autorzy :
Cho YS; Department of Clinical Pharmacology and Therapeutics, University of Ulsan, Seoul, Republic of Korea.
Noh YH; Hallym Institute for Clinical Medicine, Hallym University Medical Center, Anyang, Gyeonggi-do, Republic of Korea.
Lim HS; Department of Clinical Pharmacology and Therapeutics, University of Ulsan, Seoul, Republic of Korea.
Cho SH; Department of Clinical Pharmacology and Therapeutics, Inha University, Incheon, Republic of Korea.
Ghim JL; Department of Clinical Pharmacology, Korea University Anam Hospital, Seoul, Republic of Korea.
Choe S; Clinical Trials Center, Pusan National University Hospital, Busan, Republic of Korea.
Kim SB; Department of Internal Medicine, University of Ulsan, Seoul, South Korea.
Park JS; Department of Internal Medicine, University of Ulsan, Seoul, South Korea.
Lee SK; Department of Internal Medicine, University of Ulsan, Seoul, South Korea.
Yang WS; Department of Internal Medicine, University of Ulsan, Seoul, South Korea.
Chang JW; Department of Internal Medicine, University of Ulsan, Seoul, South Korea.
Bahng MY; Department of Product Development, Dong-A ST, Seoul, Republic of Korea.
Bae KS; Department of Clinical Pharmacology and Therapeutics, University of Ulsan, Seoul, Republic of Korea.
Pokaż więcej
Źródło :
Journal of clinical pharmacology [J Clin Pharmacol] 2018 Jul; Vol. 58 (7), pp. 905-912. Date of Electronic Publication: 2018 Mar 14.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Phosphodiesterase 5 Inhibitors/*pharmacokinetics
Pyrimidines/*pharmacokinetics
Renal Insufficiency/*metabolism
Sulfonamides/*pharmacokinetics
Administration, Oral ; Adult ; Aged ; Area Under Curve ; Female ; Humans ; Male ; Middle Aged ; Young Adult
Czasopismo naukowe
Tytuł :
Pharmacokinetics of atorvastatin and sustained-release metformin fixed-dose combination tablets: two randomized, open-label, 2-way crossover studies in healthy male subjects under fed conditions.
Autorzy :
Choi YK; Department of Pharmacology and PharmacoGenomics Research Center, Inje University College of Medicine, Busan 47392, Republic of Korea.
Park SE; Department of Pharmacology and PharmacoGenomics Research Center, Inje University College of Medicine, Busan 47392, Republic of Korea.
Kim EY; Department of Pharmacology and PharmacoGenomics Research Center, Inje University College of Medicine, Busan 47392, Republic of Korea.; Department of Clinical Pharmacology, Inje University Busan Paik Hospital, Busan 47392, Republic of Korea.
Park HJ; CJ HealthCare Co., Ltd., Seoul 04560, Republic of Korea.
Kim EJ; CJ HealthCare Co., Ltd., Seoul 04560, Republic of Korea.
Song GS; CJ HealthCare Co., Ltd., Seoul 04560, Republic of Korea.
Ghim JL; Department of Clinical Pharmacology, Inje University Busan Paik Hospital, Busan 47392, Republic of Korea.
Pokaż więcej
Źródło :
Translational and clinical pharmacology [Transl Clin Pharmacol] 2017 Dec; Vol. 25 (4), pp. 190-195. Date of Electronic Publication: 2017 Dec 20.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Role of the ABCB1 Drug Transporter Polymorphisms in the Pharmacokinetics of Oseltamivir in Humans: a Preliminary Report.
Autorzy :
Cha YJ; Department of Clinical Pharmacology and Toxicology, Korea University Anam Hospital, Korea University College of Medicine, Seoul, Korea.
Ghim JL; Department of Clinical Pharmacology and Toxicology, Korea University Anam Hospital, Korea University College of Medicine, Seoul, Korea. jonglyul.ghim@gmail.com.
Pokaż więcej
Źródło :
Journal of Korean medical science [J Korean Med Sci] 2017 Sep; Vol. 32 (9), pp. 1542-1547.
Typ publikacji :
Clinical Trial; Journal Article
MeSH Terms :
Pharmacogenomic Variants*
Oseltamivir/*pharmacokinetics
ATP Binding Cassette Transporter, Subfamily B/genetics ; Administration, Oral ; Adult ; Alleles ; Chromatography, High Pressure Liquid ; Genotype ; Half-Life ; Heterozygote ; Humans ; Male ; Oseltamivir/blood ; Polymorphism, Single Nucleotide ; Sequence Analysis, DNA ; Tandem Mass Spectrometry
Czasopismo naukowe
Tytuł :
Population Pharmacokinetic-Pharmacodynamic Analysis to Compare the Effect of Moxifloxacin on QT Interval Prolongation Between Healthy Korean and Japanese Subjects.
Autorzy :
Choi HK; Department of Pharmacology and PharmacoGenomics Research Center, Inje University College of Medicine, Busan, Republic of Korea.
Jung JA; Department of Pharmacology and PharmacoGenomics Research Center, Inje University College of Medicine, Busan, Republic of Korea; Department of Clinical Pharmacology, Inje University Busan Paik Hospital, Busan, Republic of Korea.
Fujita T; Kitasato University Hospital, Clinical Trial Center, Kanagawa, Japan; Kitasato University School of Medicine, Department of Pharmacology, Kanagawa, Japan.
Amano H; Kitasato University School of Medicine, Department of Pharmacology, Kanagawa, Japan.
Ghim JL; Department of Clinical Pharmacology and Toxicology, Anam Hospital, Korea University College of Medicine, Seoul, Republic of Korea.
Lee DH; Department of Clinical Pharmacology, Busan National University Hospital, Busan, Republic of Korea.
Tabata K; Kitasato University School of Medicine, Department of Urology, Kanagawa, Japan.
Song ID; Kitasato University Hospital, Clinical Trial Center, Kanagawa, Japan; Kitasato University Graduate School of Medical Sciences, Kanagawa, Japan.
Maeda M; Kitasato University Hospital, Clinical Trial Center, Kanagawa, Japan; Kitasato University Graduate School of Medical Sciences, Kanagawa, Japan.
Kumagai Y; Kitasato University Hospital, Clinical Trial Center, Kanagawa, Japan; Kitasato University School of Medicine, Kitasato Clinical Research Center, Kanagawa, Japan.
Mendzelevski B; Cardiac Safety Consultants LTD, London, England.
Shin JG; Department of Pharmacology and PharmacoGenomics Research Center, Inje University College of Medicine, Busan, Republic of Korea; Department of Clinical Pharmacology, Inje University Busan Paik Hospital, Busan, Republic of Korea. Electronic address: .
Pokaż więcej
Źródło :
Clinical therapeutics [Clin Ther] 2016 Dec; Vol. 38 (12), pp. 2610-2621.
Typ publikacji :
Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial
MeSH Terms :
Anti-Bacterial Agents/*adverse effects
Fluoroquinolones/*adverse effects
Heart Conduction System/*drug effects
Heart Rate/*drug effects
Adult ; Anti-Bacterial Agents/pharmacokinetics ; Anti-Bacterial Agents/pharmacology ; Asian Continental Ancestry Group ; Cross-Over Studies ; Double-Blind Method ; Electrocardiography ; Female ; Fluoroquinolones/pharmacokinetics ; Fluoroquinolones/pharmacology ; Humans ; Male ; Moxifloxacin ; Young Adult
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies